Liver X receptor activation reduces gastric cancer cell proliferation by suppressing Wnt signalling via LXRβ relocalization

J Cell Mol Med. 2019 Feb;23(2):789-797. doi: 10.1111/jcmm.13974. Epub 2018 Oct 19.

Abstract

Liver X receptors (LXRs) are involved in various diseases associated with lipid disorders, and in regulating cancer cell proliferation. However, the underlying molecular mechanisms, especially those in gastric cancer (GC) remain to be clarified. In this study, immunohistochemistry analysis revealed that LXRβ was mainly expressed in GC tissue, with less expression in adjacent normal tissues. The LXRβ agonist T0901317 efficiently suppressed the proliferation and colony formation of various GC cell lines. We further showed that LXRβ translocated from the cytoplasm to the nucleus when activated by T0901317. LXRβ nuclear localization suppressed the activation of Wnt signalling and decreased the expression of target genes such as MYC, BMP4, and MMP7 through binding to their promoters. Moreover, we demonstrated that the LXR agonist efficiently suppressed GC tumour growth in a nude mouse xenograft model. Taken together, these results revealed that LXRβ agonist inhibited GC cells proliferation by suppressing Wnt signalling via LXRβ relocalization. The results strongly suggest that LXRβ could be a promising target in GC therapy.

Keywords: LXRβ; Wnt signalling; cell proliferation; gastric cancer; translocation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Bone Morphogenetic Protein 4 / antagonists & inhibitors
  • Bone Morphogenetic Protein 4 / genetics
  • Bone Morphogenetic Protein 4 / metabolism
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Cell Proliferation / drug effects
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Hydrocarbons, Fluorinated / pharmacology*
  • Liver X Receptors / agonists
  • Liver X Receptors / genetics*
  • Liver X Receptors / metabolism
  • Male
  • Matrix Metalloproteinase 7 / genetics
  • Matrix Metalloproteinase 7 / metabolism
  • Mice
  • Mice, Nude
  • Middle Aged
  • Promoter Regions, Genetic
  • Protein Binding
  • Protein Transport
  • Proto-Oncogene Proteins c-myc / antagonists & inhibitors
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / pathology
  • Sulfonamides / pharmacology*
  • Tumor Burden / drug effects
  • Wnt Signaling Pathway
  • Xenograft Model Antitumor Assays

Substances

  • Anticholesteremic Agents
  • Antineoplastic Agents
  • BMP4 protein, human
  • Bone Morphogenetic Protein 4
  • Hydrocarbons, Fluorinated
  • Liver X Receptors
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • Sulfonamides
  • T0901317
  • MMP7 protein, human
  • Matrix Metalloproteinase 7